Literature DB >> 15073748

Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance.

R D Mann1, L V Wilton, G L Pearce, F J Mackay, N R Dunn.   

Abstract

Year:  1997        PMID: 15073748     DOI: 10.1002/(SICI)1099-1557(199710)6:3+<S5::AID-PDS272>3.0.CO;2-F

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  14 in total

1.  Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports.

Authors:  D Clark; D Layton; S A Shakir
Journal:  BMJ       Date:  2001-09-29

2.  The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies.

Authors:  R M Martin; N R Dunn; S Freemantle; S Shakir
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

3.  Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists.

Authors:  R M Martin; N R Dunn; S N Freemantle; R D Mann
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 4.  Prescription-event monitoring--recent progress and future horizons.

Authors:  R D Mann
Journal:  Br J Clin Pharmacol       Date:  1998-09       Impact factor: 4.335

5.  Tolerability of alendronate. Comparison group taking placebo should have been included.

Authors:  M Kirby
Journal:  BMJ       Date:  1998-05-02

6.  Age- and gender-specific asthma death rates in patients taking long-acting beta2-agonists: prescription event monitoring pharmacosurveillance studies.

Authors:  R M Martin; S Shakir
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

7.  Systematic review and guide to selection of selective serotonin reuptake inhibitors.

Authors:  J G Edwards; I Anderson
Journal:  Drugs       Date:  1999-04       Impact factor: 9.546

8.  Antidepressants and the serotonin syndrome in general practice.

Authors:  F J Mackay; N R Dunn; R D Mann
Journal:  Br J Gen Pract       Date:  1999-11       Impact factor: 5.386

9.  Post-marketing studies: the work of the Drug Safety Research Unit.

Authors:  F J Mackay
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

10.  Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies.

Authors:  R M Martin; P N Biswas; S N Freemantle; G L Pearce; R D Mann
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.